Retro
retro.bioDeveloper of cellular reprogramming, autophagy, and plasma-inspired therapeutics designed to increase healthy human lifespan.
LBX PPS
1Y return
$14.57
Last Round
May 2026
Later Stage VC
Later Stage VC · $1.8B
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...